368 related articles for article (PubMed ID: 33367520)
1. Analysis of the Molecular Signature of Breast Implant-Associated Anaplastic Large Cell Lymphoma in an Asian Patient.
Kim IK; Hong KY; Lee CK; Choi BG; Shin H; Lee JH; Kim MK; Gu MJ; Choi JE; Kim TG
Aesthet Surg J; 2021 Apr; 41(5):NP214-NP222. PubMed ID: 33367520
[TBL] [Abstract][Full Text] [Related]
2. Anaplastic Large-Cell Lymphoma Associated with Breast Implants: A Case Report of a Transgender Female.
Patzelt M; Zarubova L; Klener P; Barta J; Benkova K; Brandejsova A; Trneny M; Gürlich R; Sukop A
Aesthetic Plast Surg; 2018 Apr; 42(2):451-455. PubMed ID: 29101436
[TBL] [Abstract][Full Text] [Related]
3. Breast implant-associated ALK-negative anaplastic large cell lymphoma: a case report and discussion of possible pathogenesis.
George EV; Pharm J; Houston C; Al-Quran S; Brian G; Dong H; Hai W; Reeves W; Yang LJ
Int J Clin Exp Pathol; 2013; 6(8):1631-42. PubMed ID: 23923082
[TBL] [Abstract][Full Text] [Related]
4. EUSOMA position regarding breast implant associated anaplastic large cell lymphoma (BIA-ALCL) and the use of textured implants.
Cardoso MJ; Wyld L; Rubio IT; Leidenius M; Curigliano G; Cutuli B; Marotti L; Biganzoli L
Breast; 2019 Apr; 44():90-93. PubMed ID: 30703669
[TBL] [Abstract][Full Text] [Related]
5. An Unusual Case of BIA-ALCL Associated with Prolonged/Complicated Biocell-Textured Expander, followed by Smooth Round Breast Implant Exposure, and Concurrent Use of Adalimumab.
Akhavan AA; Wirtz EC; Ollila DW; Bhatt N
Plast Reconstr Surg; 2021 Aug; 148(2):299-303. PubMed ID: 34133406
[TBL] [Abstract][Full Text] [Related]
6. Oncological Outcomes After Multidisciplinary Management of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL).
O'Connell RL; Sharma B; El-Sharkawi D; Wotherspoon A; Attygalle AD; MacNeill F; Khan AA; Tasoulis MK
Ann Surg Oncol; 2023 Oct; 30(10):6170-6175. PubMed ID: 37454017
[TBL] [Abstract][Full Text] [Related]
7. Molecular Drivers of Breast Implant-Associated Anaplastic Large Cell Lymphoma.
Blombery P; Thompson ER; Prince HM
Plast Reconstr Surg; 2019 Mar; 143(3S A Review of Breast Implant-Associated Anaplastic Large Cell Lymphoma):59S-64S. PubMed ID: 30817557
[TBL] [Abstract][Full Text] [Related]
8. Breast Reconstruction Following Breast Implant-Associated Anaplastic Large Cell Lymphoma.
Lamaris GA; Butler CE; Deva AK; Miranda RN; Hunt KK; Connell T; Lipa JE; Clemens MW
Plast Reconstr Surg; 2019 Mar; 143(3S A Review of Breast Implant-Associated Anaplastic Large Cell Lymphoma):51S-58S. PubMed ID: 30817556
[TBL] [Abstract][Full Text] [Related]
9. Breast Implant-Associated Anaplastic Large Cell Lymphoma: Proposal for a Monitoring Protocol.
Santanelli di Pompeo F; Laporta R; Sorotos M; Di Napoli A; Giovagnoli MR; Cox MC; Campanale A; Longo B
Plast Reconstr Surg; 2015 Aug; 136(2):144e-151e. PubMed ID: 26218387
[TBL] [Abstract][Full Text] [Related]
10. Differences in Human Leukocyte Antigen Expression Between Breast Implant-Associated Anaplastic Large Cell Lymphoma Patients and the General Population.
Tevis SE; Hunt KK; Miranda RN; Lange C; Butler CE; Clemens MW
Aesthet Surg J; 2019 Sep; 39(10):1065-1070. PubMed ID: 30715139
[TBL] [Abstract][Full Text] [Related]
11. Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL) and the Textured Breast Implant Crisis.
K Groth A; Graf R
Aesthetic Plast Surg; 2020 Feb; 44(1):1-12. PubMed ID: 31624894
[TBL] [Abstract][Full Text] [Related]
12. Cell of Origin and Immunologic Events in the Pathogenesis of Breast Implant-Associated Anaplastic Large-Cell Lymphoma.
Turner SD; Inghirami G; Miranda RN; Kadin ME
Am J Pathol; 2020 Jan; 190(1):2-10. PubMed ID: 31610171
[TBL] [Abstract][Full Text] [Related]
13. Nonmalignant CD30+ Cells in Contralateral Peri-Implant Capsule of Patient With BIA-ALCL: A Premalignant Step?
Kadin ME; Xu H; Hunsicker LM; Guan Y
Aesthet Surg J; 2022 Jan; 42(2):NP125-NP129. PubMed ID: 33944901
[TBL] [Abstract][Full Text] [Related]
14. Breast implant associated anaplastic large cell lymphoma: The UK experience. Recommendations on its management and implications for informed consent.
Johnson L; O'Donoghue JM; McLean N; Turton P; Khan AA; Turner SD; Lennard A; Collis N; Butterworth M; Gui G; Bristol J; Hurren J; Smith S; Grover K; Spyrou G; Krupa K; Azmy IA; Young IE; Staiano JJ; Khalil H; MacNeill FA
Eur J Surg Oncol; 2017 Aug; 43(8):1393-1401. PubMed ID: 28596034
[TBL] [Abstract][Full Text] [Related]
15. UK Guidelines on the Diagnosis and Treatment of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL) on behalf of the Medicines and Healthcare products Regulatory Agency (MHRA) Plastic, Reconstructive and Aesthetic Surgery Expert Advisory Group (PRASEAG).
Turton P; El-Sharkawi D; Lyburn I; Sharma B; Mahalingam P; Turner SD; MacNeill F; Johnson L; Hamilton S; Burton C; Mercer N
J Plast Reconstr Aesthet Surg; 2021 Jan; 74(1):13-29. PubMed ID: 33483089
[TBL] [Abstract][Full Text] [Related]
16. Cellular and Molecular Mechanisms of Breast Implant-Associated Anaplastic Large Cell Lymphoma.
DeCoster RC; Clemens MW; Di Napoli A; Lynch EB; Bonaroti AR; Rinker BD; Butterfield TA; Vasconez HC
Plast Reconstr Surg; 2021 Jan; 147(1):30e-41e. PubMed ID: 33370049
[TBL] [Abstract][Full Text] [Related]
17. IL-13 is produced by tumor cells in breast implant-associated anaplastic large cell lymphoma: implications for pathogenesis.
Kadin ME; Morgan J; Xu H; Epstein AL; Sieber D; Hubbard BA; Adams WP; Bacchi CE; Goes JCS; Clemens MW; Medeiros LJ; Miranda RN
Hum Pathol; 2018 Aug; 78():54-62. PubMed ID: 29689246
[TBL] [Abstract][Full Text] [Related]
18. Does Breast Implant-Associated ALCL Begin as a Lymphoproliferative Disorder?
Kadin ME; Adams WP; Inghirami G; Di Napoli A
Plast Reconstr Surg; 2020 Jan; 145(1):30e-38e. PubMed ID: 31577659
[TBL] [Abstract][Full Text] [Related]
19. Spontaneous Regression and Resolution of Breast Implant-Associated Anaplastic Large Cell Lymphoma: Implications for Research, Diagnosis and Clinical Management.
Fleming D; Stone J; Tansley P
Aesthetic Plast Surg; 2018 Jun; 42(3):672-678. PubMed ID: 29445921
[TBL] [Abstract][Full Text] [Related]
20. Ruptured breast implant removal because of patient anxiety in the absence of breast implant-associated anaplastic large cell lymphoma.
Takahashi H; Sato H; Tsunekawa Y; Fujioka U; Wanifuchi-Endo Y; Toyama T; Toriyama K
Nagoya J Med Sci; 2023 Nov; 85(4):852-856. PubMed ID: 38155618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
